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ABSTRACT
Cytotoxic Activity of Non-Specific Lipid Transfer Protein (nsLTP1) and Proteomic
Evaluation of Heparin-Binding Proteins from Ajwain (Trachyspermum ammi) Seeds
by Saud O. Alshammari
Trachyspermum ammi, commonly known as ajwain, is a member of the Apiaceae family. It is a
therapeutic herbal spice with diverse pharmacological properties, used in traditional medicine for
various ailments. However, all previous studies were conducted using small molecule extracts,
leaving the protein’s bioactivity undiscovered. The present study demonstrated the
antiproliferative activity of ajwain nsLTP1 in MCF-7, AsPC-1, and MCF10A cell lines and its
structural stability in human serum and high-temperature conditions.
The antiproliferative activity of ajwain nsLTP1 was evaluated in MCF-7 and AsPC-1 cell lines
using an MTT assay. Annexin V-FITC and PI staining were used to detect the early apoptotic and
late apoptotic cells. The role of nsLTP1 in inducing apoptosis was further studied by quantifying
Bcl-2, Bax, Caspase-3, Survivin, EGFR, and VEGF genes expression using RT-PCR. CD
spectroscopy analyzed the nsLTP1 conformational changes after thermal treatment for structure
stability determination. The RP-HPLC was used to analyze the nsLTP1 degradation rate in human
serum at different time intervals incubated at 37°C.
Ajwain nsLTP1 showed a potent antiproliferative effect in MCF-7 and AsPC-1. The IC50 value
obtained in MCF-7 was 8.21 µM, while for AsPC-1 4.17 µM. The effect of nsLTP1 on stimulating
apoptosis revealed that the proportions of apoptotic cells in both cell lines were relatively increased
depending on the concentration. The apoptotic cells percentage at 20 µM was in MCF-7 71%
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(***P < 0.001) and AsPC-1 88% (***P < 0.001). These results indicate that nsLTP1 might
efficaciously induce apoptosis in multiple types of cancerous cells. Genes expression in MCF-7
and AsPC-1 showed significant upregulation in Bax and Caspase-3 and downregulation in Bcl-2,
Survivin, EGFR, and VEGF Proteins. The CD analysis showed a significant proportion of α-helical
structure, indicating nsLTP1 has the thermostable property. In serum, nsLTP1 showed a slow
degradation rate, indicating high stability with a half-life of ⁓ 8.4 h.
Our results revealed the potential anticancer activity of ajwain nsLTP1 and its mechanism in
inducing apoptosis. It further exhibited thermostable properties at high temperatures and in human
serum, which suggested this protein as a potent and stable cancer agent.
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1

INTRODUCTION

Herbs and plants have been adapted for medicinal purposes for thousands of years. Human use of
plants dates back to around 60,000 years ago in the middle Paleolithic age (Maridass & Britto,
2008; Petrovska, 2012). The term herb refers to any plant or part of a plant used for medicinal,
aromatic, or flavoring purposes, such as its leaves, flowers, bark, seeds, and fruits (Kunle et al.,
2012). Many civilizations have used medicinal plants for over 4,000 years as remedies for various
ailments, including Egypt, China, Greece, India, and the Mediterranean. Nowadays, the World
Health Organization (WHO) reports that more than 80% of the world's population relies primarily
on traditional medicines for their primary health care.
The study of medicinal plants has contributed directly to drug discovery through the development
of pure drugs, indirectly by providing raw materials for the development of semisynthetic
derivatives, and as model molecules for the design of lead molecules (Veeresham, 2012). A new
era of plant-based herbal medicines was born in the 19th century due to the discovery,
substantiation, and isolation of alkaloids in plants such as poppy, ipecacuanha, strychnos, quinine,
and pomegranate. Nevertheless, scientific pharmacy started with the isolation of glycosides.
Through advanced techniques, new substances from medicinal plants, such as tannins,
saponosides, etheric oils, vitamins, and hormones, have been discovered (Petrovska, 2012).
Natural products or their derivatives account for approximately one-third of all new molecular
entities. The United States Food and Drug Administration (FDA) approved 59 drugs in 2018;
approximately 16% were natural products or drugs based on natural products (G. de la Torre &
Albericio, 2019; Patridge et al., 2016). Also, in Europe, about a quarter of all the European Medical
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Agency (EMA) approved drugs are plant-based (Thomford et al., 2018). However, medicinal
plants still serve as core structures for synthetic drugs and remain an integral part of drug research
and development, despiting new drug design advances (Berdigaliyev & Aljofan, 2020).
Life-threatening diseases have become one of the most global healthcare concerns (Namisango et
al., 2019). However, cancer is still one of the most significant causes of death with high morbidity
and mortality. According to International Agency for Research on Cancer, the globally estimated
number of cancer cases in 2020 was 19.3 million (Figure 1.1). In 112 countries, cancer is
considered the first leading cause of death in the young population, with almost 10 million deaths
in 2020 (Sung et al., 2021). Additionally, the United States alone has had 1,806,590 new cancer
cases and 606,520 cancer deaths in the last year. Among different cancers types, breast cancer is
the most diagnosed cancer in women, with 2.3 million new cases in 2020 (Siegel et al., 2020).
Moreover, it has been reported that breast cancer families with BRCA1 and BRCA2 mutations
have been linked to an increased risk of pancreatic cancer (Mocci et al., 2013). Despite all
advanced technologies and new treatment approaches, the cancer survival rate is still very low for
multiple types, including the pancreas (9%) (Siegel et al., 2020).

2

Figure 1-1. The estimated number of the new cancer cases and cancer deaths worldwide in 2020
(GLOBOCAN 2020).

1.1

Breast Cancer

Breast cancer is one of the most common malignancies in women and is a molecularly
heterogeneous

disease

(Harbeck

et

al.,

2019).

Molecular

characterization

and

immunohistochemistry classify breast cancer in the modern era. Invasive ductal carcinoma and
invasive lobular carcinoma (80% to 85% and 10% to 15%, respectively) are the two most common
histologic subtypes of invasive breast cancer (Bhattacharyya et al., 2020). Physical symptoms and
3

psychosocial distress in breast cancer patients can affect good quality of life. Several factors affect
life quality for patients, including the physical and mental impact of illness, diagnostics and
therapeutics, stress, pain, depression, and disease effects on family, marriage, and social
relationships, as well as induced economic burdens, nutritional issues, and treatment complications
(Perry et al., 2007). In terms of economic burden, breast cancer comprises direct costs, morbidity
and mortality costs. In 2019, according to the National Institutes of Health, breast cancer the outof-pocket costs were estimated at $3.14 billion (Annual Report to the Nation Part 2, 2021).

1.1.1 Risk Factors of Breast Cancer
Breast cancer cannot be prevented entirely. However, changing factors within your control, such
as risk factors, might lower your risk. According to the American Cancer Society (ACS), the risk
factors are classified into risk factors that cannot be changed and can be changed. For instance,
increasing age, genetic mutations, dense breasts, and family history are considered factors that
cannot be changed. On the other hand, not being physically active, obesity after menopause, taking
hormones, Breast implants, drinking alcohol, and cigarette smoking all can be avoided by changing
the lifestyle. Additionally, the highest risk of having breast cancer is strongly linked to family
history and inherited changes in BRCA1 and BRCA2 genes (Breast Cancer Risk Factors and
Prevention Methods, 2019).
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1.1.2 Treatment of Breast Cancer
Treatment options are often dependent on various factors, including the cancer type, stage,
hormone receptor status, and the patient's age. In the early stages of breast cancer, when the cancer
is contained within the breast or has spread only to the axillary lymph nodes, cancer is curable in
~70–80% of the patients. In the early stages, radiation or chemotherapy is usually combined with
surgery to treat breast cancers (Harbeck et al., 2019). In contrast, the current therapeutic options
are not suitable for treating advanced (metastatic) diseases. However, patients with metastatic
diseases may be considered for systemic therapies such as chemotherapy, hormonal therapy, and
biological therapy (CDC, 2022; Schirrmacher, 2019).
1.1.2.1 Surgery
In the early stages of breast cancer, the primary treatment method is surgery. There are two types
of surgery used to remove the tumor, including breast-conserving surgery and mastectomy. Breastconserving surgery, also known as lumpectomy, involves removing the cancerous cells and some
normal cells surrounding them. Tumor size and location also play a role in determining how much
breast is removed. The entire breast should be removed in a mastectomy, including other nearby
tissues. Women may also undergo a double mastectomy in which both breasts are removed (Czajka
& Pfeifer, 2022; Waks & Winer, 2019).
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1.1.2.2 Radiation Therapy
Despite its associated side effects, radiation therapy remains an important part of cancer treatment.
It is often administered after surgery to treat early-stage breast cancer. It is used to kill cancer cells
to reduce the possibility of recurrence after surgery (Haussmann et al., 2020). Following the
surgical removal of cancer, radiotherapy is used to destroy any remaining cancer cells. Both
cancerous and healthy cells are damaged during radiation therapy, but cancer cells are more
strongly affected. Cancer cells divide and multiply more rapidly than healthy cells and are less
organized than healthy cells. Cancer cells can thus more easily be damaged by radiation, while
healthy cells are better able to repair themselves and survive the radiation. Radiation damage is
more accessible to heal healthy cells than cancer cells (Herron et al., 2013; R. Lin & Tripuraneni,
2011).
1.1.2.3 Chemotherapy
Many medications are in clinical use, categorized by their mechanism of action. These include
alkylating agents, topoisomerase inhibitors that inhibit DNA unwinding and transcription,
antibiotics, antimetabolites, and mitotic inhibitors, which stop cell division during mitosis.
Additionally, steroids are given in the regimen to alleviate chemotherapy-associated side effects.
In patients with invasive tumors at greater risk of recurrence or breast cancer spread to surrounding
organs, chemotherapy is often prescribed. In addition to cardiotoxicity, nephropathy,
neurotoxicity, infertility, and liver damage, chemotherapy is often associated with severe side
effects (Claessens et al., 2020; Lagunes & Pezo, 2021).
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1.1.2.4 Hormone Therapy
Hormonal therapy can treat breast cancer that is hormone receptor-positive such as estrogen or
progesterone. It acts by reducing the production of hormones or preventing them from attaching
to cancer receptors. Post-surgery, chemotherapeutic agents are often used to decrease the chance
of cancer relapse. Additionally, hormone therapy reduces the tumor size before surgery to be
surgically removed. Breast cancer mortality rates have decreased with hormonal treatment, and
survival rates have improved (Krauss & Stickeler, 2020; Tremont et al., 2017).
1.1.2.5 Immunotherapy
Cancer immune therapy uses cell debris/viral vectors to stimulate the immune system to destroy
tumor cells. Immunotherapy includes vaccines, monoclonal antibodies, cytokines, and
lymphocytes that assist the immune system in killing cancer cells (Syn et al., 2017). For instance,
cancer vaccine therapies train the immune system to select the cancer cells without damaging the
normal cells. Vaccines that have passed clinical trials have shown more promising outcomes in
various cancer types; however, they still need to be combined with surgery or chemotherapy
(Banchereau & Palucka, 2005; O’Mahony et al., 2005). Also, monoclonal antibodies are another
example of immunotherapy that targets overexpressed receptors (tumor antigens) and induces the
immune response. Therefore, the specificity, efficacy, and low toxicity of immunotherapy could
improve cancer treatment outcomes (Weiner et al., 2010).
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1.2

Pancreatic Cancer

Worldwide, pancreatic cancer is the fourth leading cause of cancer-related deaths and continues to
be a significant public health concern because it is associated with a very poor prognosis. The
pancreatic cancer survival rate is still very low compared to other cancers, with the highest
mortality rate. Most patients are diagnosed at advanced stages, and only 10-15% of them can
undergo surgical resection, with a 5% survival rate. Currently, surgical treatment is the only
approach to treat this type of cancer (Bilici, 2014). Further, the chemotherapy agents are only used
with inoperable or metastatic patients. Pancreatic cancer has several types: adenocarcinoma,
adenosquamous carcinomas, squamous cell carcinomas, signet ring cell carcinomas, and
ampullary cancer. The most common type of pancreatic cancer is adenocarcinoma, with
approximately 95% of all diagnosed cases, and usually starts to develop in the ducts of the
pancreas (Figure 1-2) (ACS, 2019; McGuigan et al., 2018).
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Figure 1-2. Pancreatic ductal adenocarcinoma. (https://www.mayoclinic.org/diseasesconditions/pancreatic-cancer/symptoms-causes/syc-20355421)

9

1.2.1 Risk Factors of Pancreatic Cancer
There are two types of risk factors non-modifiable and modifiable. Age, sex, ethnicity, and family
history are considered non-modifiable factors, while smoking, alcohol, obesity, and diet are
modifiable factors. It is unlikely that patients are diagnosed with pancreatic cancer before the age
of 30; however, 90% of newly diagnosed patients are older than 55. Based on sex, males are more
likely to develop pancreatic cancer than females (WHO, 2018). Also, ethnicity plays a major role
in pancreatic cancer in the United States, African Americans have a 50%-90% higher risk of
pancreatic cancer than Caucasians, but Pacific Islanders and Asian-Americans have the lowest
incidence rates (Midha et al., 2016). In addition, Families with a history of pancreatic cancer are
nine times more likely to develop the disease than those without. This risk increases to thirty-two
times higher when three or more first-degree relatives have had pancreatic cancer (Becker et al.,
2014).

1.2.2 Treatment of Pancreatic Cancer
The only effective treatment for pancreatic cancer is surgical resection; however, chemotherapy is
used as adjuvant therapy, and it has been shown to improve the survival rate when combined with
resection. In general, several factors determine the clinical management of pancreatic cancer
patients, such as overall health and wellness and personal preferences. Currently, gemcitabine is a
commonly used drug in pancreatic cancer patients. It was initially developed as an antiviral drug
in the 1980a, but it showed significant anti-neoplastic activities. In 1996, the FDA approved
gemcitabine as adjuvant chemotherapy for pancreatic cancer and was considered a standard-ofcare agent for the advanced stages. However, the survival rate increased by two years in only 4 %
of patients (Principe et al., 2021).
10

1.3

Apoptosis in Cancer

Circumvention of apoptosis is a common feature of all malignant cells. There is an imbalance
between cell division and cell death in cancerous cells due to sequential genetic changes and
alterations in the signal transduction pathways resulting in deregulation of the apoptosis process
(Sever & Brugge, 2015; Wong, 2011). Understanding the apoptosis process is extremely important
because it gives insight into the pathogenesis of disease and the possible treatment mechanisms.
Apoptosis is a programmed mechanism of activated cell death response to cell stress or growth
factor deprivation. It is initiated by either the mitochondrial (intrinsic) pathway or the death
receptor (extrinsic) pathway (Fulda & Debatin, 2006). Both paths lead to the activation of caspases,
which are responsible for DNA and protein breakdown. Therefore, down-regulation of antiapoptotic proteins and up-regulation of proapoptotic proteins will enhance anticancer activity by
inducing apoptosis (Naseri et al., 2015). Current treatment approaches such as surgery, radiation,
and small molecules chemotherapy have massive side effects, which demand researchers and
pharmaceutical industries to develop a new effective treatment with fewer adverse effects. Proteinbased drugs extracted from plants and other natural organisms might have a significant role in drug
development and the discovery of new cancer agents (Hew et al., 2013a; Khalifa et al., 2019; Y.
Wang et al., 2019).
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1.4

Non-Specific Lipid Transfer Proteins

Based on multiple reports, nonspecific Lipid Transfer Proteins (nsLTPs) possess anticancer
activities against several cancer types. Plant nsLTPs are cysteine-rich proteins classified based on
their molecular mass into two subfamilies, nsLTP1 (9-10 kDa) and nsLTP2 (6-7 kDa) (Finkina et
al., 2016). Their structure is stabilized by four disulfide bonds formed between eight cysteine
residues (Salminen et al., 2016). Functionally, they are characterized by their ability to bind with
lipid molecules and transfer them between membranes. They are also involved in the plant’s innate
immunity, especially the signaling pathways (Boutrot et al., 2008). Both nsLTPs were successfully
purified and characterized from various plants species (Jain & Salunke, 2017; Lei et al., 2014;
Meijer et al., 1993; Ooi et al., 2008; Samuel et al., 2002; Takishima et al., 1988; Wei & Zhong,
2014; Zaman & Abbasi, 2009). In the in-vitro experiments, nsLTPs from fennel seeds (Foeniculum
vulgare) and cole seeds (Brassica campestris) showed anticancer activity against breast cancer cell
line (MCF-7) (Lin et al., 2007; Megeressa et al., 2020). In addition, the cytotoxic effect of nsLTP
isolated from Peganum harmala seeds has been observed in four cancer cell lines, including
melanoma (B16), esophagus carcinoma (Eca-109), gastric carcinoma (MGC-7), and cervical
carcinoma (HeLa) (Ma et al., 2013). Their cytotoxic activity studies remain limited despite all
discovered nsLTPs from different plants. Previously, we have reported the extraction, purification,
amino acid sequence, and molecular modeling of nsLTP1 from ajwain seeds (Nazeer et al., 2019).
The complete primary structure established is deposited to the UniProt Knowledgebase under the
accession number C0HLG2, https://www.uniprot.org/uniport/C0HLG2. Subsequently, our in
silico investigation presents 3D modeling, docking patterns, and dynamic interactions of ajwain
nsLTP1 with different ligands. The coordinate file of ajwain nsLTP1 is submitted to the online
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protein model database (PMDB). The PMDB ID of the submitted model is PM0081852. This study
evaluates the nsLTP1 cytotoxic activity extracted from ajwain (Trachyspermum ammi).

1.5

Trachyspermum ammi

The ajwain (Trachyspermum ammi) is also known as ajowan, caraway, bishop’s weed, or carom
seeds (Figure 3-1). It belongs to the plant family Umbelliferae or Apiaceae. Members of this
family are well known for their therapeutic properties. In traditional medicine, ajwain seeds are
commonly used to relieve various ailments such as colic, dyspepsia, and diarrhea (Bairwa et al.,
2012). Also, previous experiments showed pharmacological properties, including antibacterial
(Kaur & Arora, 2008; Zaidi et al., 2009), antifungal (Dwivedi & Singh, 1998), anthelmintic
(Mathew et al., 2008), antihypertensive, hepatoprotective (Gilani et al., 2005), anti-inflammatory
(Thangam & Dhananjayan, 2003), and antioxidant (Anilakumar et al., 2009).

1.5.1 Taxonomical Classification of Trachyspermum ammi
Kingdom

Plantae, Plant

Sub-kingdom

Tracheobionta, Vascular plants

Super-division Spermatophyta, Seed plants
Division

Magnoliophyta, Flowering plants

Class

Magnoliopsida, Dicotyledons

Subslass

Rosidae
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Order

Apiales

Family

Apiaceae

Genus

Trachyspermum

Species

Ammi

Commons

Ajwain, ajowan, and ajowan caraway

A

B

Figure 1-3. Ajwain (Trachyspermum ammi). (A) Seeds; (B) Flower.

1.5.2 Phytochemistry
The evaluation of the ajwain seed has exhibited it to contain carbohydrates (38.6%), fat (18.1%),
protein (15.4%), fiber (11.9%), tannins, glycosides, moisture (8.9%), and saponins, flavone and
mineral matter (7.1%) (Figure 1-4). The essential oil of ajwain fruits yields 2-4 %, with a major
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constituent of thymol (35-60%). A highly hygroscopic saponin is found in alcohol extracts (Bairwa
et al., 2012).

Figure 1-4. Phytoconstituents of ajwain (Trachyspermum ammi).

1.6

Significance of the study

For centuries, the plants were used by humans to heal common illnesses and even prevent them.
Different parts of the plants, such as leaves, flowers, bark, seeds, and fruit, were involved in
discovering new drugs because they possess various active chemical constituents. Over the last 20
years, a third of the medicines approved by the Food and Drug Administration (FDA) were natural
products based or their derivatives. However, due to herbal products' rising use globally, the major

15

concern is their effectiveness and safety. Hence, before using an herb as a medicine, it must be
proven to be active and safe (Chattopadhyay & Maurya, 2015; Woo et al., 2012).
Natural products and their derivatives play a major role in high efficacy and less toxicity to various
ailments, especially cancer (Demain & Vaishnav, 2011). Several proteins/peptides showed
significant anticancer activity. Pentapeptide isolated from rice bran was found to be inhibited colon
cancer cells, breast cancer cells, and liver cancer cells by 84%, 80%, and 84%, respectively
(Kannan et al., 2010). Besides, the protein extracts from Momordica charantia and Trigonella
foenumgraecum seeds possess anticancer activity against multiple cancer cell lines (Abozaid et al.,
2014). In another study, Gynura procumbens protein extract has shown anticancer activity against
breast cancer cell lines (Hew et al., 2013b). This information revealed the vital role of the extracted
bioactive proteins and peptides in treating several cancer types (Hernández-Ledesma et al., 2013).
The Apiaceae family or Umbelliferae is a highly valued medicinally important seed spice known
as the celery, carrot, or parsley family. It contains commercially significant species, such as ajwain,
fennel, caraway, dill, carrot, anise, and parsley (Tamokou et al., 2017). Some species of this family
are poisonous, including poison-hemlock (Conium maculatum) and Water hemlock (Cicuta
maculata) (San Andrés Larrea et al., 2014; Simpson, 2010). In multiple studies, the Apiaceae
family have been explored to possess an enormous activity for many diseases and conditions, for
instance, in the treatment of hemorrhoids, intestinal worms, sickness, headaches, stimulant,
digestive, and also against cancer cell proliferation (Filiz et al., 2016; Rosselli et al., 2009).
This project will be conducted on ajwain seeds (Trachyspermum ammi) belonging to the Apiaceae
family. Ancient Egypt is the origin of this plant. The shape of its seeds is oval, while the color is
light brown. The high number of phytochemicals presented in ajwain seeds makes them highly
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valued medicinally important seeds. The seed extract is reported to treat several diseases, such as
urinary tract disorders, digestive problems, cough, tonsillitis, and pulmonary disorders (Jan et al.,
2015; Singh & Kale, 2009). However, a published study showed that the nsLTP protein extracted
from fennel seeds has activity against the breast cancer MCF7 cell line (Megeressa et al., 2020).
On the other hand, no studies were conducted to evaluate the biological activities of the proteins
and peptides extracted from ajwain seeds, especially nsLTP, reported recently (Nazeer et al.,
2019). Therefore, this project will focus on the isolation, purification, characterization, and
evaluation of the biological activities of nsLTP and other proteins and peptides. Cell-based
anticancer assays will be conducted using MCF7, MCF10A, and AsPC-1 cell lines. Also,
identification of heparin‐binding proteins from ajwain (Trachyspermum ammi) seeds will be
performed.
In 1995, Marc R. Wilkins used the proteome term to describe a protein as a genome's complement
(Wasinger et al., 1995). Leigh Anderson defines proteomics as the use of quantitative protein-level
measurements of gene expression to characterize biological processes (e.g., disease processes and
drug effects) and decipher the mechanisms of gene expression control" (Anderson & Anderson,
1998). The advanced technologies, such as mass spectrometry and bioinformatics data analysis,
promoted the progression of isolation and characterization of peptides/proteins from various
plants. A new technique named De novo sequencing can now be performed using the
bioinformatics software package, PEAKS Studio-X. It is used to characterize the amino acid
sequence, which is not present in available protein sequence databases (Zhang et al., 2012).
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1.7

Objective of the study

1.7.1 General objectives
 To evaluate the cytotoxic activity of nsLTP1 isolated from ajwain (Trachyspermum ammi)
seeds.
 Affinity

proteomics-based

analysis

of

heparin‐binding

proteins

from

ajwain

(Trachyspermum ammi) seeds.

1.7.2 Specific objectives
 To evaluate in vitro cytotoxic activity of nsLTP1 on (MCF-7 breast cancer and MCF 10A
normal breast cell lines) and (AsPC-1 pancreatic cancer cell lines).
 To analyze the mechanism underlying nsLTP1-induced cancer cell death in MCF-7 and
AsPC-1 using flow cytometry.
 To evaluate the molecular mechanistic explanation by expressing pro-apoptotic and antiapoptotic genes in MCF-7 and AsPC-1 cancer cell lines treated with nsLTP1.
 To evaluate the effect of thermal treatments on nsLTP1 secondary structure.
 To evaluate in vitro human serum stability of nsLTP1.
 To evaluate the lipid-binding potential of nsLTP1 using a fluorescence-based lipid-binding
assay.
 Identification of heparin‐binding proteins from ajwain (Trachyspermum ammi) seeds.
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2

METHODOLOGY

Ajwain seeds were authenticated based on morphology by Dr. Muneeba Khan, Taxonomist at the
Center for Plant Conservation, University of Karachi Herbarium and Botanical Garden. As per
institutional policy, seeds are not accepted as a voucher specimen, but no deposition number is
issued required for the whole plant.

2.1

Extraction, Purification, and Characterization of nsLTP1 from Ajwain
(Trachyspermum ammi) Seeds

2.1.1 Extraction of Proteins
Ajwain (Trachyspermum ammi) seeds were ground, and the powder was defatted using n-hexane
for 24 h. Hexane was removed by filter paper, and the solid mass recovered dried at room
temperature for 2 days in the chemical hood. The dried defatted powder was blended in 20 mM
Tris/HCl pH 8 buffer and stirred for 4 days at 4ºC. The sample was filtered through a cheesecloth.
The recovered filtrate was centrifuged at 14,000 rpm using Thermo Scientific™ Sorvall LYNX
4000 Superspeed Centrifuge for 30 min. The supernatant was collected and precipitated with 80%
ammonium sulfate at 4ºC and stirred for 24 h. Precipitated proteins were recovered by
centrifugation at 14,000 rpm for 10 min. The pelleted proteins were dissolved in deionized water
and dialyzed using dialysis tubing (MWCO 3.5 kDa) for 2 days at 4 ºC. The dialyzed samples were
lyophilized using a lyophilizer (Domżalska et al., 2016). The samples were stored at 4ºC for further
experiments. The schematic workflow adopted in this project is presented in Figure 2-1
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Figure 2-1. Schematic of workflow of ajwain seeds project.
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2.1.2 Fast Protein Liquid Chromatography (FPLC)
2.1.2.1 Gel Filtration Chromatography
AKTA Pure (GE Healthcare) fast protein liquid chromatography (FPLC) equipped with HiPrep
Sephacryl S-200 HR26/60 column was used to fractionate the crude proteins based on their
molecular weight. The column was equilibrated with 20 mM Tris/HCl, pH 8 buffer in isocratic
elution mode at 1 mL flow rate, and the absorbance was monitored at 214 nm.
2.1.2.2 Affinity Chromatography
AKTA start (GE Healthcare) equipped with HiTrap Heparin column was used to fractionate the
crude proteins into two fractions (heparin-binding proteins and heparin-unbinding proteins). In the
gradient elution, two buffers were used (A: 10 mM sodium phosphate pH 7 and B: 10 mM sodium
phosphate + 1 mM NaCl. The flow rate was 1 mL/min, and absorbance was measured at 280 nm.

2.1.3 Reversed-Phase High-Performance Liquid Chromatography (RPHPLC)
The second-dimensional chromatography purification process was continued using RP-HPLC,
using a Vydac C4 (2.1x150mm) column. The Hitachi Elite LaChrom HPLC system equipped with
pump L-2130, Diode Array Detector L-2455, Refrigerated auto-sampler L-2200, and software
package EZChrom Elite (version 3.3.2 SP2) was used. The fractions obtained from gel filtration
chromatography were further fractionated based on their hydrophobicity properties. The samples
were eluted by a gradient 0-60% B (0.1% acetonitrile) for 85 min at a flow rate 1 mL/min and
absorbance at 214 nm.
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2.1.4 Electrophoresis
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed using
tris/tricine 10 % separating gel and 4% stacking gel. The gel recipe is listed in Table 2-1. (Schägger
& von Jagow, 1987). The separating gel solution was poured into a gel cassette, and then spraying
70% ethanol as an overlay on the top of the separating gel. After 20-30 minutes, the ethanol layer
was removed before adding the stacking gel. The stacking gel was prepared, the comb was placed
immediately before stacking gel polymerization. The samples were prepared by mixing 50% of
protein and 50% tricine gel loading buffer containing 2% of 2 β-Mercaptoethanol and boiled at
95°C for 10 min. The samples at 10 μL were loaded into the stacking gel and 10 μL of standard
protein (ladder). The proteins were separated under an electrical current of 200 V for 45 minutes
using the 1x-Tris/tricine/SDS running buffer. The gels were stained with the Coomassie Blue for
2 h and then destined using water overnight. Gels were imaged using the ChemiDocTM Imaging
system (Bio-Rad).
Table 2-1. Recipe of gel casting solution for 10% separating and 4% stacking gels
Gel Casting Solution

10% Separating gel

4% Stacking gel

40% Acrylamide/Bis (29:1)

3.75 mL

400 μL

Water
3 M Tris/HCl pH 8.45 containing 0.3%
SDS

3.75 mL

775 μL

2.62 mL

1950 μL

50% Glycerol

1.125 mL

N/A

TEMED

15 μL

10 μL

30% APS

15 μL

10 μL
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2.1.5 MALDI-TOF Mass Spectrometry
MALDI-TOF mass spectrometer (Autoflex Speed, Bruker, USA) was used to analyze the purified
intact nsLTP1. A 1 μL of the nsLTP1 in 0.1% TFA-water and 1 μL of the matrix 3,5-dimethoxy4-hydroxycinnamic acid (SPA) prepared in 50% acetonitrile containing 0.1%TFA were mixed and
applied to MALDI plate. The mixture was air-dried before the analysis.

2.1.6 Protein Oxidation and Digestion
The heparin-binding proteins fraction were oxidized using performic acid and digested with
trypsin. The performic acid was made by mixing 1 vol. Fresh 30% hydrogen peroxide (H2O2)
with 9 vol. 100% formic acid. Then, the mixture was incubated at room temperature in the dark
for 1 h to allow performic acid to form. The protein samples were mixed with 50 μL of performic
acid and incubated in ice for 2 h, 1 mL H2O was added and speed-vac to remove the acid before
lyophilization. The next step was to add 50 mM Tris/HCl, pH 8 to the samples, and the pH was
adjusted to 8.0. The trypsin was prepared in 50 mM tris/HCl pH 8.0 and added in a ratio of 1:20
(Trypsin: Protein). The mixture was incubated overnight (<16 h) at 37℃. The next day, the
digestion was stopped by adding acetic acid until pH 4.0 was reached.

2.1.7 LC-MS/MS Q-TOF Mass Spectrometry
The tryptic digest of ajwain heparin-binding proteins fraction was analyzed using Impact II™
UHR-QqTOF (Ultra-High Resolution Qq-Time-of-Flight) mass spectrometry instrument along
with Phenomenex BioZen 2.6 μm Peptide XB-C18 (pore size 100 Å, dimension 150×2.1) column.
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The mobile phase used was solvent A: 0.1% formic acid in water and solvent B: 0.1% formic acid
in ACN at a 0.3 mL/min flow rate. The elution gradient was 0-55% B in 45 min.

2.1.8 MS/MS Data Analysis
De novo sequencing by PEAKS bioinformatics software was used. The MS/MS data was
generated as the data file called mascot generic files (mgf). These data were used to search in
PEAKS studio software.

2.1.9 Gene Ontology Annotation
Annotation of gene ontology from the identified proteins was obtained from UniProt
Knowledgebase (UniProtKB) gene ontology (GO) project (https://www.uniprot.org/uniprot/). The
proteins were categorized based on their biological process, molecular functions, and cellular
compartment.

2.2

Antiproliferative Activity of Ajwain nsLTP1 on MCF-7, MCF10A, and
AsPC-1 Cells

Human breast cancer MCF-7 (ATCC HTB-22), pancreatic cancer AsPC-1 (ATCC CRL-1682),
and normal breast MCF10A (ATCC CRL-10317) cell lines (ATCC, Manassas, USA) were
cultured at 37ºC with 5% CO2. The MCF-7 cancer cells were maintained in Dulbecco’s Modified
Eagle Medium (DMEM) and AsPC-1 in the Roswell Park Memorial Institute (RPMI) mediums,
supplemented with 10% (v/v) of fetal bovine serum (FBS) and 1% (v/v) penicillin-streptomycin.
The normal breast cells MCF10A was maintained in mammary epithelial cell basal medium
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(MEBM), supplemented with mammary epithelial cell growth medium (MEGM) growth factors
(Lonza, USA).

2.2.1 Protein Estimation
The Coomassie (Bradford) protein assay kit (Thermo Scientific) was used to estimate the total
protein concentration. PBS was used as a diluent for BSA standard as following concentrations:
2,000, 1,500, 1,000, 750, 500, 250, 125, 25 g/mL, and blank. Using a 96-well plate, 2 μL of protein
extract and an equal amount of BSA were mixed and triplicated added. Then, 250 μL of Coomassie
Plus Reagent solution was added to each sample and incubated in the dark for 10 min. The samples
were analyzed using SpectraMax M5 UV/VIS Plate Reader to measure the absorbance at 595 nm.
The concentration was obtained by calculating the average reading of the triplicate results.

2.2.2 Cell Viability Assay Using MTT
The cytotoxic effect of nsLTP1 extracted from Ajwain seeds was evaluated using MTT [3-(4, 5dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide] assay (Mosmann, 1983). A total of
3x104 cells/mL were added to 96 well plates in 200 µL medium (10,000 cells/well) and incubated
for 24 hours at 37ºC with 5% CO2. The medium was removed the next day, and different
concentrations (2.5, 5, 10, 15, and 20 µM) of purified nsLTP1 were used to treat the cells and
calculate the IC50. Doxorubicin was used as a positive control, whereas untreated cells were
negative control. After 48 h incubation, the treatments were replaced with MTT dye (0.5 mg/mL
in medium), followed by 4 hours of incubation at 37°C and 5% CO2. After discarding the dye, 100
μL DMSO was added to solubilize the purple-blue colored formazan crystal. SpectraMax M5
Microplate Reader was used to measure the absorbance at 550 nm. This experiment was repeated
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three times in triplicate, and the following equation was used to calculate the percentage of
inhibition:

% Inhibition =

Absorbance of Neg. control − Absorbance of treated cells
x100
Absorbance of Neg. control

2.2.3 Apoptosis Assay by Flow Cytometry
Cell apoptosis detection assay was performed using a commercially available kit (FITC Annexin
V Apoptosis Detection Kit II (BD Biosciences, USA) as per the manufacturer’s instructions.
Briefly, after cells treatment with nsLTP1 (5, 10, and 20 µM) and without in 6-well plates for 48
h, cold PBS was used to wash the cells twice and 1X binding buffer to resuspend them at a
concentration of 1x106 cells/mL. Annexin V (5 μL) and propidium iodide (PI) (5 μL) were mixed
with 100 μL of the suspended cells in a culture tube, followed by 15 min incubation at room
temperature in the dark. The mixture was diluted by adding 400 μL of 1X binding buffer and
immediately analyzed using flow cytometry, FACS Verse (BD Biosciences, USA). This
experiment was repeated independently three times in triplicate (Livak & Schmittgen, 2001).
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2.2.4 RNA Extraction
After cell lines (MCF-7 and AsPC-1) treatment in 6-well plates for 48 h with different
concentrations of nsLTP1 (5, 10, and 20 µM), the mRNA was extracted using the TRIzol reagent
(Invitrogen, USA) following the manufacturer’s protocol. Briefly, 1 mL TRIzol reagent was added
to lyse the cells after removing the medium. The cells were collected in Eppendorf tubes and
incubated at room temperature for 5 min. Chloroform was added (0.2 mL) and mixed with the cells
for 15 sec. The samples were centrifuged at 12000 RPM for 15 min and 4°C to obtain phase
separation. The aqueous phase was transferred into a new tube and mixed with 0.5 ml of 100%
isopropanol and incubated for 10 min to precipitate RNA, then centrifuged at 12,000 RPM at 4°C
for 10 min. After removing the supernatant, the RNA pellet was mixed with 75% ethanol (1 mL)
followed by centrifugation at 7500 RPM for 5 min 4°C. Nuclease-free water (30 µL) was added
to resuspend the dried RNA pallet. The RNA purity and quantity were determined using NanoDrop
One (Thermo Scientific) spectrophotometer. The purified RNA integrity was determined after
diluting the samples in loading buffer (6X) and running on 1.2% agarose gel electrophoresis
containing ethidium bromide at 80 V for 45 min. The BioRad ChemiDoc XRS+ was used to
visualize the gel and determine RNA integrity.

2.2.5 cDNA Synthesis
The yields of RNA were approximately 2 µg from each cell line which were reverse transcribed
to cDNA using RevertAid First Strand cDNA synthesis kit (Thermo Fisher Scientific; Cat no.
#k1622). The kit components were added as shown in the Table 2-2. Then the mixture was heated

at 65°C for 5 min, followed by adding the cDNA synthesis kit components shown in Table 2-3.
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Table 2-2. RNA and primer used for cDNA synthesis
Reagents

Amount

RNA Template

1 µg

Random Hexamer Primer

1 µL

Nuclease Free Water

Up to 12 µL

Total volume

12 µL

Table 2-3. cDNA synthesis kit reagents
Reagents

Amount

5X Reaction Buffer

4 µL

Ribolock RNase Inhibitor

1 µL

10 mM dNTP Mix

2 µL

RevertAid M-MuLV RT

1 µL

Total Volume

20 µL
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Then, the samples were centrifuged, and cDNA synthesis was performed under the following
thermal cycling conditions, 5 min incubation at 25°C, followed by 60 min at 42°C, and 5 min
heating at 70°C. After cDNA synthesis was performed, samples were diluted 10 times and stored
at -20°C for the next experiment.

2.2.6 Real-Time PCR for Gene Expression Analysis
The cDNA was used to quantify Bcl2, BAX, caspase-3, surviving, EGFR, and VEGF gene
expressions by Real-Time Polymerase Chain Reaction (RT-PCR). For each of these targeted
genes, the sequence of forward and reverse primers is listed in Table 2-4. Reactions were
performed using Maxima SYBR Green/ROX qPCR master mix kit (Thermo Fisher Scientific) in
QuantStudio 3 Real-Time thermocycler (Applied Biosystems, Thermo Fisher Scientific) under the
following conditions: 95°C for 10 min followed by 40 cycles of 95°C for 15 sec and 55°C for 60
sec. GAPDH was used as the housekeeping gene. Fold change in gene expression was calculated
using the 2-ΔΔCt method and presented as the mean ± SD relative to untreated cells in three
independent triplicate experiments (Livak & Schmittgen, 2001).

Where ∆∆ct = [ct gene of interest (treated) – ct gene of interest (untreated)] – [ct GAPDH (treated)
– ct GAPDH (untreated)].
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Table 2-4. Sequence of Forward and Reverse Primers Used in Gene Expression
Quantification by Real-Time PCR
Gene

Forward Primer

Reverse Primer

Bcl-2

5´-AGGATTGTGGCCTTCTTTG-3´

5´-ACAGTTCCACAAAGGCATCC-3´

BAX

5´-AGATCATGAAGACAGGGGCC-3´

5´-GCAATCATCCTCTGCAGCTC-3´

Caspase-3

5´-ATGGAAGCGAATCAATGGAC-3´

5´-ATCACGCATCAATTCCACAA-3´

Survivin

5´-CAGAGTCCCTGGCTCCTCTAC-3´

5´-GGCTCACTGGGCCTGTCTA-3´

EGFR

5´-CCAACCAAGCTCTCTTGAGG-3´

5´-GCTTTCGGAGATGTTGCTTC-3´

VEGF

5´-CTACCTCCACCATGCCAAGT-3´

5´-CACACAGGATGGCTTGAAGA-3´

GAPDH

5´-CCAGAACATCATCCCTGCCT-3´

5´-CCTGCTTCACCACCTTCTTG-3´
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2.3

Circular Dichroism (CD) Spectroscopy

The CD analysis was performed using a JASCO J-1500 spectropolarimeter equipped with the
Peltier Jasco PTC-510 temperature controller (Jasco Corp., Japan) under the following conditions:
Nitrogen flow 20 SCFH, PM-539 detector, data interval 0.1 nm, data pitch 0.1 nm, CD scale 200
mdeg/0.1 dOD, FL scale 200 mdeg/0.1 dOD, bandwidth 1 nm, cell length 1 mm, start mode
immediately, scanning mode continuous, scanning speed 50 nm/min, and shutter control auto. An
average of three readings between 190 and 260 nm was collected for each sample. MilliQ water
was used to subtract the background. The sample was scanned at 20, 40, 60, 80, and 95°C for 20
min, and then cooled to 20°C for 20 min before being scanned again. Under the same conditions
and parameters, collagen was used as a control to compare the conformational changes in the
secondary structure after thermal treatment. Analysis was carried out using one of the multivariate
regression analyses, Principal Component Regression (PCR), with a basis set containing 26
proteins reference set under the following conditions: standardization of result 100, replaced
negative value to zero, and rejection percentage 1%.

2.4

Ajwain nsLTP1 Stability

2.4.1 In Vitro Stability Assay in Human Serum
Analytical RP-HPLC was used to analyze the nsLTP1 stability studies; 25% of human serum (250
µL serum + 750 µL sterile water) was mixed with 20 µM of nsLTP1 and incubated at 37ºC. At
different time intervals (0, 3, 6, 12, 24, 48, and 72 h), several aliquots (100 µL) were diluted in
200 µL cold methanol and kept for 10 min on ice to precipitate the proteins. The samples were
centrifuged at 10000 RPM for 10 min; the supernatant was injected into Aeris Widepore-C4 (250
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× 4.6 mm) column running with a gradient of 0–60% acetonitrile with 0.1% trifluoroacetic acid
(TFA) in 65 min. The elution flow rate was 1 mL/min, and the absorbance was detected at 214
nm. The degradation of nsLTP1 was confirmed by measuring the area under the curve (AUC) after
each run.

2.4.2 In Vitro Stability Assay in Cell Culture Medium Containing FBS
Analytical RP-HPLC was used to analyze the nsLTP1 stability studies; a cell culture medium
containing 10% FBS was mixed with 20 µM of nsLTP1 and incubated at 37ºC. At different time
intervals (0, 3, 6, 12, 24, 48, and 72 h), several aliquots (100 µL) were diluted in 200 µL cold
methanol and kept for 10 min on ice to precipitate the proteins. The samples were centrifuged at
10000 RPM for 10 min; the supernatant was injected into Aeris Widepore-C4 (250 × 4.6 mm)
column running with a gradient of 0–60% acetonitrile with 0.1% TFA in 65 min. The elution flow
rate was 1 mL/min, and the absorbance was detected at 214 nm. The degradation of nsLTP1 was
confirmed by measuring the area under the curve (AUC) after each run.

2.5

In Vitro Lipid Binding Assay

TNS (6-p-Toluidino-2-naphthalene sulfonic acid) was used to evaluate the ability of ajwain
nsLTP1 to bind with lipid. The protocol used was adapted from a previous report with slight
modifications (Melnikova et al., 2016). SpectraMax M5 Microplate Reader was used to perform
the fluorescence experiment at an emission wavelength of 437 nm and excitation of 320 nm at
25°C. 3.5 μM TNS was incubated with and without lipids for 1 min in 1 mL buffer containing 175
mM mannitol, 0.5 mM K2SO4, 0.5 mM CaCl2, 5 mM MES, pH 7.0 before the initial fluorescence
record (Fo). Saturated (linoleic acid and linolenic acid) and unsaturated (palmitic acid and stearic
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acid) fatty acids were used. Dimethyl sulfoxide (DMSO) was used to prepare the FAs at different
concentrations of 5 μM, 10 μM, 15 μM, and 20 μM. Ajwain nsLTP1 (4 μM) was added to each
concentration and incubated for 2 min, then fluorescence was recorded (F). After, the nsLTP1TNS complex fluorescence percentage was calculated using the following formula:
(F − F𝐨𝐨)
x100
Fc
where Fc is the fluorescence of the nsLTP-TNS complex without lipid.

2.6

Statistical Analysis

GraphPad Prism 9.3.1 software (La Jolla, CA, USA) was used to analyze the experimental data.
In comparing two or more groups, the one-way ANOVA (analysis of variance) was used, followed
by Dunnett’s post-hoc test to determine the statistical significance. Results with P values of < 0.05
were considered statistically significant and presented as *P < 0.05, **P < 0.01, ***P < 0.001.
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3

RESULTS

3.1

Extraction, Purification, and Characterization of nsLTP1 from Ajwain
(Trachyspermum ammi) Seeds

3.1.1 Protein Extraction and Precipitation
The first step of crude proteins extraction was done by immersing ajwain seeds in 100% hexanes
for 24 h to remove the fatty acids. 20 mM Tris/HCl pH 8.0 buffer was used in the extraction
process. The precipitation of proteins was successfully performed using 80% ammonium sulfate,
which has properties including low density and relatively inexpensive compared to other protein
precipitation techniques and high solubility in aqueous buffers. Ammonium sulfate extracted
proteins recovered by precipitation based on “salting out.” This step helped remove small
molecules and non-protein soluble components from the extracts.

3.1.2 Gel Filtration Chromatography
The fractionation of ajwain seeds crude proteins was accomplished using AKTA Pure (GE
Healthcare) fast protein liquid chromatography (FPLC) equipped with HiPrep Sephacryl S-200
HR26/60 column. The crude protein 50 mg/mL was loaded onto a gel filtration column that
purified proteins according to their molecular size in elution order from high to small size,
considered first-dimensional purification. The column was equilibrated with 20 mM Tris/HCl, pH
8.00 buffer in isocratic elution mode at a 1 mL/min flow rate, and absorbance monitored at 214
nm. Major peaks were collected for further analysis using tris/tricine gels SDS-PAGE based on
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the elution profile, including F3-4, F5, F6-9, F10-13, F14-17, F18-21, F22-23, and F24-27 (Figure

Absorbance at 214 nm

3-1).

Volume (mL)
Figure 3-1. Gel filtration elution profile of ajwain seeds crude protein on Sephacryl S-200 HR26/60
column. Elution buffer 20 mM Tris/HCl, pH 8.0. Flow rate 1 mL/min and absorbance was
measured at 214 nm.

35

3.1.3 Electrophoresis
The tris/tricine gel SDS-PAGE was successfully performed for the gel filtration fractions extracted
from ajwain seeds. The fraction 24-27 was observed to have a protein band around 10 kDa, and
further analysis confirmed that band correspond to nsLTP1 (Figure 3-2).

Figure 3-2. Tris/tricine gel electrophoretic profile of ajwain seeds protein fractionated by gel
filtration chromatography. STD, standard molecular weight marker.
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3.1.4 Reversed Phase High Performance Liquid Chromatography (RP-HPLC)
The second-dimensional chromatography purification process was achieved using RP-HPLC,
using a Vydac C4 (2.1x150mm) column. The pooled fractions (F24-27) obtained from gel filtration
chromatography was further purified based on hydrophobicity properties. The sample was eluted
at 35 min retention time by a gradient 0-60% B (0.1% acetonitrile) in 85 min at a flow rate 1

Absorbance at 214 nm

mL/min and absorbance at 214 nm as shown in Figure 3-3.

Retention time (min)
Figure 3-3. Ajwain seeds RP-HPLC elution profile of pooled gel filtration fractions 24-27. Column:
Vydac C4 (2.1x150mm), gradient: 0-60% acetonitrile in 85 min, flow rate 1 mL/min and
absorbance at 280 nm.

37

3.1.5 MALDI-TOF Mass Spectrometry
MALDI-TOF mass spectrometry was used to identify the RP-HPLC purified intact nsLTP1
molecular mass. In Figure 3-4, the mass observed in the spectra was 9672.0508 Da, while the

Intensity [a.u.]

theoretically calculated mass of the nsLTP1 amino acids sequence was 9.663 Da.

m/z
Figure 3-4. MALDI-TOF mass spectra of RP-HPLC purified ajwain nsLTP1.
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3.1.6 Antiproliferative effect of nsLTP1 on breast, pancreatic cancer cells, and
normal breast cells
3.1.6.1 MCF-7 and AsPC-1
The activity of purified nsLTP1 from ajwain seeds against MCF-7 and AsPC-1 cell lines was
evaluated using the MTT assay. After quantifying the concentrations by Bradford assay, nsLTP1
was screened at different doses (2.5, 5, 10, 15, and 20 µM). In a dose-dependent manner, our
results showed a potent antiproliferative effect in MCF-7 and AsPC-1 compared to the untreated
control cells (Figure 3-5A). After 48 h treatment, the 20 µM dose significantly suppressed the
proliferation of MCF-7 and AsPC-1 by 80% (***P < 0.001) and 89% (***P < 0.001), respectively.
The IC50 concentrations were calculated using nonlinear regression analysis; for MCF-7, the value
was 8.21 µM, while for AsPC-1 4.17 µM, indicating that nsLTP1 is more potent against AsPC-1.
Also, a dose-dependent inhibition was observed for doxorubicin (positive control) in both cell lines
with IC50 values of 0.4224 μM (MCF-7) and 0.2786 μM (AsPC-1), as shown in Figure 3-5B.
3.1.6.2 MCF10A
The cytotoxic effect of purified nsLTP1 against normal breast cells (MCF10A) was evaluated
using the MTT assay. The cells were treated for 48 h at different doses of nsLTP1 (2.5, 5, 10, 15,
and 20 µM), showing less toxicity. At 20 µM, the percent of inhibition was 23%, which was more
than 80% with cancer cells (Figure 3-6A). The doxorubicin (positive control) showed a potent
toxic effect in normal cells; at 1 µM, the inhibition percent was 90%, with IC50 values of 0.3767
μM, as shown in Figure 3-6B.
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Figure 3-5. Dose-dependent cytotoxic activity of Ajwain nsLTP1 after 48 h treatment. Data from
three independent experiments are presented with mean and standard deviation (SD) highlighted
as *P < 0.05, **P < 0.01, ***P < 0.001. (A) nsLTP1 calculated IC50 values in MCF-7 and AsPC1 were 8.21 µM and 4.17 µM, respectively. (B) Left side showed doxorubicin calculated IC50 value
as 0.4224 µM in MCF-7, whereas right side showed doxorubicin calculated IC50 value as 0.2786
µM in AsPC-1.
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Figure 3-6. The cytotoxic effect of (A) ajwain nsLTP1 and (B) doxorubicin on MCF10A
normal breast cell line after 48 h treatment with different concentrations. Data from three
independent experiments are presented with mean and standard deviation (SD).

41

3.1.7 Effect of nsLTP1 on Stimulating Apoptosis
To investigate the role of nsLTP1 in stimulating apoptosis, MCF-7 and AsPC-1 cells were treated
with various concentrations (5, 10, and 20 µM) and without for 48 h. Apoptosis was detected using
Annexin-V and Propidium Iodide (PI) staining, and the number of apoptotic cells was counted in
the lower right (early apoptosis) and upper right (late apoptosis) quadrants. As depicted in Figure
3-7A & Figure 3-8A, the proportions of apoptotic cells in both cell lines were relatively increased
depending on the concentration. In comparison with control, the apoptotic cells percentage at 20
µM was increased significantly in MCF-7 to 71% (***P < 0.001) (Figure 3-7A) as well as in
AsPC-1 to 88% (***P < 0.001) (Figure 3-8A). The percentage of apoptosis among different
concentration treatments is represented in Figure 3-7B (MCF-7), and Figure 3-8B (AsPC-1)
compared to untreated control cells. The data were presented as the mean ± SD of three
independent experiments. These results indicate that nsLTP1 might efficaciously induce apoptosis
in multiple types of cancerous cells. The activity was more against AsPC-1 than MCF-7, consistent
with the MTT assay results.
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Figure 3-7. Flow cytometry results with Annexin V-FITC/PI staining for the determination of
apoptotic induction after 48 h treatment with nsLTP1. (A), Cells were classified as healthy cells
(Annexin V−, PI−), early apoptotic cells (Annexin V+, PI−), late apoptotic cells (Annexin V+,
PI+), and necrotic cells (Annexin V−, PI+). In comparison to control, at 20 µM the percentage of
the apoptotic cells was in (A) MCF-7 to 71% (B), represent the percentage of apoptosis among
different concentration treatments in MCF-7 compared to untreated control cells. The sum of early
apoptotic and late apoptotic cells was considered as the percentage of apoptosis. The data were
presented as the mean ± SD of three independent experiments and significance are indicated by *P
< 0.05, **P < 0.01, ***P < 0.001.
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Figure 3-8. Flow cytometry results with Annexin V-FITC/PI staining for the determination of
apoptotic induction after 48 h treatment with nsLTP1. (A), Cells were classified as healthy cells
(Annexin V−, PI−), early apoptotic cells (Annexin V+, PI−), late apoptotic cells (Annexin V+,
PI+), and necrotic cells (Annexin V−, PI+). In comparison to control, at 20 µM the percentage of
the apoptotic cells was in (A) AsPC-1 to 88%. (B), represent the percentage of apoptosis among
different concentration treatments in AsPC-1 compared to untreated control cells. The sum of early
apoptotic and late apoptotic cells was considered as the percentage of apoptosis. The data were
presented as the mean ± SD of three independent experiments and significance are indicated by *P
< 0.05, **P < 0.01, ***P < 0.001.
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3.1.8 Effect of nsLTP1 on the Expression of Apoptosis-Related Genes
Further analysis was performed to explore the mechanism of nsLTP1 in inducing apoptosis in
MCF-7 and AsPC-1. The gene expression of pro-apoptotic (Bax and Caspase-3) and cancerassociated genes which promote cell survival (Bcl-2, Survivin, EGFR, and VEGF) were analyzed
in RT-PCR (Figure 3-9). In MCF-7, a significant upregulation fold change was observed in Bax
and Caspase-3 by 1.4-fold (**P < 0.01) and 1.5-fold (***P < 0.001), respectively, at 20 µM dose.
Also, the same dose significantly caused downregulation in Bcl-2, Survivin, EGFR, and VEGF
genes by 0.5-, 0.5-, 0.7-, and 0.4-fold, respectively (Figure 3-9A). In congruence with the MCF7 findings, Bax in AsPC-1 cells was upregulated significantly by 1.2-fold (**P < 0.01); also, in
Caspase-3, the fold change was noted at a significant level of 1.3-fold (***P < 0.001). On the other
hand, we noted a significant downregulation in the fold change of Bcl-2, Surviving, EGFR, and
VEGF genes by 0.6-, 0.7-, 0.1-, and 0.2-fold, respectively (***P < 0.001) as shown in Figure 39B. All the above data were compared to untreated control cells. The total RNA integrity was
evaluated by agarose gel electrophoresis. In Figure 3-10 & Figure 3-11, single bands of 28S and
18S; prove the integrity of the total RNA.
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Figure 3-9. Ajwain nsLTP1 mechanism of action in inducing apoptosis in MCF-7 and AsPC-1.
Both cell lines were treated with the same concentrations and compared to untreated control cells.
(A) In MCF-7, nsLTP1 promoted apoptosis by increasing the gene expression of pro-apoptotic
proteins (Bax and Caspase-3) and decreasing the anti-apoptotic protein (Bcl-2). Also, it decreased
the expression of other cancer-associated genes that promote cell survival including, Survivin,
EGFR, and VEGF. (B) In AsPC-1, nsLTP1 promoted apoptosis by upregulation the gene
expression of Bax and Caspase-3, and downregulation Bcl-2, Survivin, EGFR, and VEGF. All data
were obtained from three independent experiments and significance are indicated by *P < 0.05,
**P < 0.01, ***P < 0.001
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Figure 3-10. The integrity of total RNA samples extracted from MCF-7 after nsLTP1 treatment. 1.2%
agarose gel electrophoresis was used to evaluate the extract.

Figure 3-11. The integrity of total RNA samples extracted from AsPC-1 after nsLTP1 treatment.
1.2% agarose gel electrophoresis was used to evaluate the extract.
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3.1.9 Effect of thermal treatments on nsLTP1 secondary structure
CD spectroscopy was used to investigate the stability of nsLTP1 at various temperatures. The
spectra were recorded for nsLTP1 and the control (collagen) at temperatures ranging from 20 to
95°C and after cooling to 20°C, as shown in Fig. 4. The estimated secondary structure contents of
the protein from Principal Component Regression (PCR) of the CD spectra indicated significant
proportions of α-helical structure, as demonstrated in Table 3-1. The nsLTP1 showed the
thermostable property. There were minimal changes in the secondary structure at 95°C and after
cooling down to 20°C. The spectra before and after heating at 20°C were almost similar. The
positive maxima at 191 nm and double minima at 220 nm and 209 nm (being slightly more intense)
were the unique signatures of the protein (Figure 3-12A). PCR analysis indicated a much lower
content of β-sheet (21.9%) and turn (11.2%) compared to α-helix (32.4%) and other (34.5%) at
20°C. Therefore, the CD spectrum of nsLTP1 implies a rich protein in α-helix. When heated to
95°C, the maxima and minima decreased in intensity, reporting PCR analysis of β-sheet (2.5%),
turn (15.5%), α-helix (43.1%), and other (38.9%). PCR analysis indicated an increase in α-helix
and a corresponding decrease in β-sheet structure at 95°C. After cooling down back to 20°C, the
spectrum almost matched the before heating, retaining native-like α-helix and β-sheet structures.
In contrast, collagen was denatured as the temperature increased to 40°C and remained denatured
even after cooling it down to 20°C (Figure 3-12B). The data suggest that the ajwain nsLTP1 is
resistant to thermal denaturation, which only explains small conformational changes.
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Figure 3-12. The thermal treatments effect on ajwain nsLTP1 secondary structure. Collagen was
used as a control in this experiment. (A) nsLTP1 CD spectra were collected at 20, 40, 60, 80, 95°C,
and after colling down to 20°C. There were minimal changes in the secondary structure at 95°C;
however, it is back to the original upon cooling it down to 20°C. Whereas, (B) collagen was
denatured as the temperature increased to 40°C and remained denatured even after cooling it down
to 20°C.
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Table 3-1. Ajwain nsLTP1 secondary structure estimated by Principal Component
Regression (PCR) analysis of CD spectra.
Temperature
Before heating
20 ⁰C
40 ⁰C
60 ⁰C
80 ⁰C
95 ⁰C
After heating
20 ⁰C

α-helix
32.4%

β-sheet
21.9%

Turn
11.2%

Other
34.5%

35.5%
38.8%
43.1%
43.1%
34.9%

17.8%
13.5%
7.0%
2.5%
18.3%

12.0%
12.9%
14.0%
15.5%
11.6%

34.7%
34.8%
35.9%
38.9%
35.2%

3.1.10 Stability of nsLTP1 in Human Serum
The stability of nsLTP1 was evaluated under 37°C with a human serum to mimic the in vivo
environment (Figure 3-13). nsLTP1 showed high stability with a half-life of ⁓ 8.4 h at specific
incubation time points ranging from 0 to 72 h, as illustrated in Figure 3-13A. At 3 h incubation
time, the remaining sample percentage was 75% ± 4%, confirming the high stability. While, at 72

h, almost all the sample was released with a remaining portion of 2% ± 1%. The peak areas at a
retention time of 36 min confirmed the slow degradation rate of nsLTP1 (Figure 3-13B).
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Figure 3-13. Stability of ajwain nsLTP1 in human serum. (A) the percent remaining of nsLTP1 was
quantified for specific incubation time points ranging from 0 to 72 h using the area under the curve
(AUC) in analytical RP-HPLC. The trendline gives the half-life of ⁓ 8.4 h. Each point represents
an average of three readings. (B) Analytical RP-HPLC chromatogram over time for nsLTP1 in
human serum with absorbance detection at 214 nm. nsLTP1 peak showed at 36 min retention time.
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3.1.11 Stability of nsLTP1 in Cell Culture Medium Containing FBS
The stability of nsLTP1 was evaluated under 37°C with a human serum to mimic the in vivo
environment. nsLTP1 showed high stability with a half-life of ⁓ 6.4 h at specific incubation time
points ranging from 0 to 72 h, as illustrated in Figure 3-14. At 3 h incubation time, the remaining
sample percentage was 85% ± 5%, confirming the high stability. While, at 72 h, almost all the
sample was released with a remaining portion of 4% ± 0.5%. The peak areas at a retention time of
36 min confirmed the slow degradation rate of nsLTP1 (Figure 3-15).

Figure 3-14. Stability of ajwain nsLTP1 in cell culture medium containing 10% FBS. The percent
remaining of nsLTP1 was quantified for specific incubation time points ranging from 0 to 72 h
using the area under the curve (AUC) in analytical RP-HPLC. The trendline gives the half-life of
⁓ 6.4 h. Each point represents an average of three readings.
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Figure 3-15. Stability of ajwain nsLTP1 in cell culture medium containing 10% FBS. (A) nsLTP1
alone (B) cell culture medium containing 10% FBS alone (C-I) representing the percent remaining
of nsLTP1 quantified for specific incubation time points ranging from 0 to 72 h using the area
under the curve (AUC) in analytical RP-HPLC.
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3.1.12 In Vitro Lipid Binding Activity of Ajwain nsLTP1
The fluorescence-based assay was performed using TNS to evaluate the lipid-binding ability of
ajwain nsLTP1. The highest fluorescent intensity was accounted for the binding of TNS to the
hydrophobic cavity of nsLTP1. The TNS and FAs fluorescence mixture decreased after the
nsLTP1 addition (Figure 3-16). The results showed that the highest displaced efficiency of the
TNS probe was achieved by linoleic acid at 6-32% of the control fluorescence, while linolenic acid
was less efficient with 10-33% of the control fluorescence. However, the recorded displacement
was equal at the minimum concentration (5 µM). On the other hand, stearic acid exhibited less
displacement efficiency than linoleic acid and linolenic acid (31-65% of the control fluorescence).
The palmitic acid showed the lowest displacement with 38-60% of the control fluorescence, but at
5 µM, the efficiency was higher than stearic acid. All concentrations showed dose-dependent
manner reduction of fluorescent intensity based on the FAs concentration.

Figure 3-16. The effect of fatty acids on the fluorescence level of ajwain nsLTP1-TNS complex.
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3.2

Proteomics of Ajwain Seeds

3.2.1 Heparin Affinity Chromatography
The fractionation of ajwain seeds crude proteins into two fractions (heparin-binding proteins and
heparin-unbinding proteins) was accomplished using AKTA start (GE Healthcare) equipped with
the HiTrap Heparin 5 mL column. The column was equilibrated in buffers (A) 10 mM sodium
phosphate pH 7. The crude protein 3 mg/mL was loaded onto the heparin affinity column and
eluted unbound proteins by isocratic elution with buffer A until a baseline was achieved. The
heparin bound proteins eluted with buffer B containing10 mM sodium phosphate + 1 mM NaCl)
at a 1 mL/min flow rate, absorbance was monitored at 280 nm. Based on the elution profile in
Figure 3-17, two major peaks represent heparin-nonbinding proteins and heparin-binding proteins.

3.2.2 Electrophoresis
The tris/tricine gel SDS-PAGE was successfully performed for the heparin affinity column
fractions extracted from ajwain seeds. The fractions of heparin-binding proteins and heparinunbinding proteins were observed to have multiple protein bands ranging from 10 to 100 kDa, as
shown in Figure 3-18.
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Absorbance at 280 nm

Unbound

Bound

Volume (mL)
Figure 3-17. Heparin affinity elution profile of ajwain seeds crude protein on HiTrap Heparin
column. Elution buffers A: 10 mM sodium phosphate pH 7 and B: 10 mM sodium phosphate + 1
mM NaCl. Flow rate 1 mL/min and absorbance was measured at 280 nm.

Figure 3-18. Tris/tricine gel electrophoretic profile of ajwain seeds protein fractionated by Heparin
affinity column. STD, standard molecular weight marker, C, Crude, UN, Unbound, and B, Bound.
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3.2.3 Identification of Heparin Binding Proteins by LC-MS/MS
Heparin-binding proteins and peptides were successfully identified using LC-MS/MS. The data
obtained from LC-MS/MS were analyzed using PEAKS Studio-X software. 42 proteins were
identified; however, we only considered 16 proteins that contain 4 unique peptides matches (Table
3-2). The identified proteins were of a wide molecular mass range of 9.6 to 72.1 kDa, and the most
significant score observed for Heat shock 70 kDa protein was 259.8, while the highest coverage
of 40% was observed for Histone H3.

3.2.4 Gene Ontology Annotation
The identified proteins were classified using UniProt Gene Ontology (GO) project based on their
molecular function, biological process, and cellular compartment. Based on the molecular function
category, 33% of the proteins involved DNA binding, while 15% were in oxidoreductase activity
(Figure 3-19). The biological process category revealed that 31% of the identified proteins were
associated with the metabolic process, 23% nucleosome assembly, and 15% lipid transport (Figure
3-20). Further, most proteins were localized in the nucleus and mitochondrion (44% and 22%,
respectively) (Figure 3-21).
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Table 3-2. The list of heparin-binding proteins identified by PEAKS Studio-X software
Sequence

Unique

Molecular Mass

Identified Protein

Accession

Score

Histone H3

Q9FKQ3

135.2

40

5

15.6

P25861

252.9

31

6

36.7

P83373

215.1

29

4

35.6

Histone H4.3

Q41811

106.5

21

4

11.5

Probable histone H2A.6

A2XZN0

122.4

19

4

16.5

Histone H2A

Q9M531

122.4

19

4

16.1

Non-specific lipid-transfer

C0HLG2

169.1

18

12

9.6

Probable histone H2A.5

Q94E96

122.4

18

4

16.4

Histone H2B.3

O65819

144.9

15

4

15

Glucose and ribitol

Q5KTS5

219.2

14

14

31.5

Histone H2B.1

Q9LQQ4

144.9

14

4

16.4

Probable histone H2B.2

Q1SWQ1

144.9

14

4

16.3

Glyceraldehyde-3-phosphate

Coverage % peptides

kDa

dehydrogenase cytosolic
Malate dehydrogenase
mitochondrial

protein 1

dehydrogenase
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Histone H2B.11

P40283

144.9

13

4

16.4

60S ribosomal protein L8-1

P46286

127.7

9

4

27.9

Non-specific lipid-transfer

A0A0B4JDK

121.2

7

4

12.6

259.8

4

4

72.1

protein
Heat shock 70 kDa protein

1
P26791

Figure 3-19. Classification of identified heparin-binding proteins based on molecular function.
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Figure 3-20. Classification of identified heparin-binding proteins based on biological process.

Figure 3-21. Classification of identified heparin-binding proteins based on cellular compartment.
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4

DISCUSSION

In 1975, Kader found the first plant nsLTP in potato tuber (Kader, 1975). NsLTPs are small, highly
soluble, and basic proteins found abundantly in all land plants. Their three-dimensional structure
is stabilized by four disulfide bridges formed between an eight-cysteine motif (8-CM) in a typical
sequence pattern C-Xn-C-Xn-CC-Xn-CXC-Xn-C-Xn-C (Berecz et al., 2010). Various
hydrophobic molecules such as fatty acids, fatty acyl-coenzyme A, galactolipids, phospholipids,
and phosphatidylglycerol can be transferred between plant membranes nonspecifically through
nsLTPs. These proteins play a crucial role in many processes in plants, including stress resistance,
defense against pathogen attack, reproduction, seed germination, and pollen adhesion (Salminen
et al., 2016). However, nsLTPs biological activities are not limited to plants only; previous reports
showed their ability to inhibit the growth of human tumor cells (P. Lin et al., 2007; Megeressa et
al., 2020b). Therefore, we investigated the potential cytotoxic activity of nsLTP1 isolated from
ajwain seeds.
Plant-derived natural products have been in use for several years. Many of these approved
anticancer agents are isolated from plants (Dholwani et al., 2008). Some of the key plants derived
natural products approved as anti-tumor agents in the USA are Vinblastine, Vincristine, Taxol,
and Camptothecin (Demain & Vaishnav, 2011). Vinblastine and vincristine are alkaloids from the
Madagascar periwinkle plant (Catharanthus roseus). Herbal formulations are typically used in
Chinese medicine. According to Chinese herbal clinicians, the herbal formulations, such as
PHY906 (KD018) and flavonoids derived from Scutellaria baicalensis are affecting cancer in
multiple ways: (1) Protecting body normal cells and tissues from the side effects of
chemo/radiotherapy; (2) maximizing the effect of chemo/radiotherapy; (3) minimizing infectious
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and inflammatory complications in tissues located around carcinoma; (4) enhancing body
resistance and immunity; (5) improving the patient quality of life and prolonging life span (Hsiao
& Liu, 2010).
For a long period, ajwain seeds small molecule extracts have been well known for their
pharmacological properties; however, to the best of our knowledge, the macromolecule extracts
(especially proteins) have not been studied for their potential cytotoxic activity against cancer
cells. Thus, the crude proteins and gel filtration fractions were initially screened against MCF-7
and AsPC-1; the preliminary data showed the maximum inhibition percentage of the fractions,
which contained the highest portion of nsLTP1. The purified nsLTP1 exhibited a cytotoxic effect
against MCF-7 and AsPC-1 cells. The calculated IC50 values were 8.21 µM and 4.17 µM for MCF7 and AsPC-1, respectively, compared to the untreated cells. Also, the cytotoxic effect was
investigated using MCF10A normal breast cells, and at the higher concentration (20 µM) only
23% inhibition was recorded compared to the untreated cells. However, this effect showed
significantly less cytotoxic effects compared to the cancer cell lines. Moreover, these cytotoxic
effects were compared to two nsLTPs previously isolated from Foeniculum vulgare (tested in
MCF-7 with IC50 6.98 µM) and Brassica campestris (tested in MCF-7 and Hep G2 with IC50 1.6
µM and 5.8 µM, respectively) (P. Lin et al., 2007; Megeressa et al., 2020). Results indicate that
nsLTPs from different plants act differently against various cancer cell lines; conversely, Vigna
radiata nsLTP was inactive against MCF-7. Sequence alignment of these nsLTPs showed several
differences in their amino acid sequences, which could be the reason for the variable activity
observed.
The previous results were further supported by analyzing the number of apoptotic cells using the
flow cytometric method, which showed consistent results with the cytotoxicity assay. It is
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suggested that inducing apoptosis might be an effective cancer treatment strategy (Nachmias et al.,
2004). Our results revealed that nsLTP1 possessed a significant ability to induce apoptosis in both
MCF-7 and AsPC-1 cells. For MCF-7 cells, as compared to untreated control cells, nsLTP1
induced apoptosis at concentrations of 5 and 10 µM, almost reaching 50%. Meanwhile, the highest
apoptotic 71% was recorded at 20 µM. At 5 and 10 µM, nsLTP1 induced apoptosis in MCF-7 cells
more than that observed in AsPC-1 cells. However, at 20 µM, the apoptotic percentage of nsLTP1
in AsPC-1 was higher than that found in MCF-7 cells compared to untreated control cells, as shown
in Fig. 2A & 2B.
The mechanism of apoptosis exerted by ajwain nsLTP1 in MCF-7 and AsPC-1 was further
evaluated based on the gene expression level. We analyzed several genes associated with tumor
growth and its resistance to treatment, including Bcl-2, Bax, Caspase-3, Survivin, EGFR, and
VEGF. The Bcl-2 protein family controls the mitochondrial apoptotic pathway through
proapoptotic (Bax) and anti-apoptotic (Bcl-2) proteins. The Bax/Bcl-2 ratio imbalance will prevent
the activation of executioner Caspase-3, which is essential in initiating downstream substrates'
cleavage involved in apoptotic changes (Knight et al., 2019). This study observed a significant
upregulation in Bax and Caspase-3 and downregulation in Bcl-2 after nsLTP1 treatment, indicating
apoptosis activation in MCF-7 and AsPC-1. Survivin, a member of the inhibitor of apoptosis
protein (IAP) family, inhibits caspases activation, which eventually leads to the inactivation of the
apoptosis process. Survivin is highly expressed in cancer cells and fetal tissue; however, in
terminally differentiated cells is undetected. Its effect on angiogenesis promotion is associated
with its capability to promote vascular endothelial growth factor (VEGF) in cancer cells, which is
considered a rate-limiting step in tumor growth (Sanhueza et al., 2015). In addition, epidermal
growth factor receptor (EGFR) overexpression enhances Survivin expression in cancer cells
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through the phosphoinositide 3-kinases pathway (Q. Wang & Greene, 2005). Based on these
findings, Survivin could potentially offer a new cancer therapeutic target distinguishing between
transformed and normal cells (Yang et al., 2010). The results showed that at the highest
concentration (20 µM), nsLTP1 exhibited a significant upregulation of the expression levels of
Bax and Caspase-3 genes in MCF-7 cells compared to the untreated cells. Conversely, nsLTP1
possessed a downregulation effect on the expression levels of Bcl-2, Surviving, EGFR, and VEGF
genes. Regarding AsPC-1 cells, Bax and Caspase-3 genes expression levels were significantly
upregulated by the action of nsLTP1; however, Bcl-2, Survivin, EGFR, and VEGF genes
expression were downregulated in comparison to the untreated cells.
Protein-based drugs are becoming more important due to their ability to treat various diseases.
Despite their unique characteristics, including high activity, strong specificity, and low toxicity,
structural stability is a major hurdle for the pharmaceutical industry from fastly developing new
therapeutic proteins. For instance, the high temperature causes conformational changes (unfold) in
a protein structure, reducing their therapeutic effect or triggering severe immune responses (Liu et
al., 2017). Thus, we investigated the thermal stability of ajwain nsLTP1 using CD spectroscopy.
Interestingly, we found that nsLTP1 is a highly stable protein at 95°C temperature, suggesting it
has a melting temperature above 100°C. In other studies, in situ heating of nsLTP1 from apple
reveals that it unfolds slightly at elevated temperature and refolded upon cooling. (Sancho et al.,
2005), and no major changes were reported in the structure of LTP1 from barley in the temperature
range of 20 °C to 90 °C (Lindorff-Larsen & Winther, 2001). These data are consistent with
observations regarding the thermostability of nsLTP1, possibly due to their unique presence of
intramolecular disulfide bonds bestowing the characteristic of thermostability. In addition, after
confirming the thermostability properties of nsLTP1, evaluated its stability in human serum. The
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estimated half-life was ⁓8.4 h which is considered close to the ideal half-life (12-48 h) (Smith et
al., 2018). Also, the stability of nsLTP1 was evaluated in a cell culture medium containing 10%
FBS. The estimated half-life was ⁓6.4 h, revealing that nsLTP1 is a highly stable molecule. The
noticed half-life difference between the stability in the human serum and the cell culture medium
containing FBS was approximately 2 h which was higher in the case of human serum.
Nevertheless, the promising results of ajwain nsLTP1 in inhibiting the proliferation of breast and
pancreatic cancers could be used for further investigations to prove its potential bioactive
properties in an animal model.
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CONCLUSION

The ajwain nsLTP1 protein exerts a potential cytotoxic activity against MCF-7 and AsPC-1 cancer
cells and induces apoptosis via downregulation of anti-apoptotic proteins and upregulation of
proapoptotic proteins. Moreover, in vitro lipid binding efficiency revealed that ajwain nsLTP1 has
the lipid-binding ability. The nsLTP1 exhibited potent stability in high temperatures ranging from
20-90 °C. Further, nsLTP1 is a stable molecule in human serum and cell culture medium
containing FBS. However, to further confirm its cytotoxic effects, a in vivo study is highly
warranted.
Additionally, this study identified 16 proteins that contain 4 unique peptides matched from
heparin-binding proteins fraction using LC-MS/MS and PEAKS Studio-X software. The identified
proteins were classified based on their molecular function, biological process, and cellular
compartment using UniProt Gene Ontology (GO) project.
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Supplementary Information

Supp Fig 1. False discovery rate (FDR) curve. X axis is the number of peptides being kept. Y
axis is corresponding FDR.

Supp Fig 2. PSM score distribution. (a) Distribution of PEAKS peptide score; (b) Scatterplot
of PEAKS peptide score versus precursor mass error.

83

Supp Table 1. Search parameters used in De novo sequencing (PEAKS)
Fragment ion Tolerance

0.5

Enzyme

Trypsin
Cysteine oxidation to cysteic acid:
47.98
Dioxidation (M): 31.99

Variable Modifications

Acetylation (Protein N-term): 42.01
Pyro-glu from E: -18.01
Pyro-glu from Q: -17.03

Max Variable PTM Per Peptide

3

De novo score (%) threshold

15

Peptide hit threshold (-10lgP)

30

Merge Options

No merge

Precursor Options

Corrected

Charge Options

No correction

Filter Charge

2-8

Process

True

Associate chimera

Yes
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Supp Table 2. Result filtration parameters used in De novo sequencing (PEAKS) search
Peptide -10lgP

≥36.1%

PTM score

≥20%

Peptide mutation ion intensity

≥5%

Protein -10lgP

≥20%

Proteins unique peptides

≥2%

De novo score (%)

≥50%
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